343 related articles for article (PubMed ID: 10418448)
1. Managed care is not the "cure-all" for improving quality and controlling costs in ESRD.
Amerling R
Nephrol News Issues; 1999 Apr; 13(4):46-7. PubMed ID: 10418448
[No Abstract] [Full Text] [Related]
2. End-stage renal disease: managing quality and cost.
Li C
Health Care Innov; 1998; 8(6):32-3. PubMed ID: 10339327
[No Abstract] [Full Text] [Related]
3. Escalating health care costs: managed care organizations.
Wehrmacher WH; Leimbach WN
Compr Ther; 1998; 24(11-12):596-600. PubMed ID: 9847977
[No Abstract] [Full Text] [Related]
4. The direction of end-stage renal disease reimbursement in the United States.
Lockridge RS
Semin Dial; 2004; 17(2):125-30. PubMed ID: 15043614
[TBL] [Abstract][Full Text] [Related]
5. Challenges and directions for Medicare ESRD payment policy.
Ray NF; Ross M
Semin Nephrol; 2000 Nov; 20(6):565-76. PubMed ID: 11111858
[TBL] [Abstract][Full Text] [Related]
6. Should the exception be lifted that disallows ESRD patients from enrolling in managed care programs?
McCarthy D
Nephrol News Issues; 1999 Oct; 13(10):12-3, 20. PubMed ID: 10827670
[No Abstract] [Full Text] [Related]
7. Don't overlook disease management programs for low-incidence, high-cost diseases to improve your bottom line.
Bruce D; Dickmeyer J
J Health Care Finance; 2001; 28(2):45-9. PubMed ID: 11794756
[TBL] [Abstract][Full Text] [Related]
8. Medicare coverage changes force a DM approach to ESRD.
Healthc Demand Dis Manag; 1998 Dec; 4(12):184-6. PubMed ID: 10339124
[TBL] [Abstract][Full Text] [Related]
9. Drugs take the spotlight in steering clinical, economic direction for ESRD.
Neumann ME
Nephrol News Issues; 2004 Jun; 18(7):50-1. PubMed ID: 15232997
[No Abstract] [Full Text] [Related]
10. Assessing Medicaid managed care in eastern state.
Kovner AR
J Policy Anal Manage; 1996; 15(2):276-84. PubMed ID: 10848160
[TBL] [Abstract][Full Text] [Related]
11. Reimbursement and ESRD. The future of managed care and the ESRD program.
Latos D; White M
Nephrol News Issues; 1995 Jul; 9(7):11. PubMed ID: 7566196
[No Abstract] [Full Text] [Related]
12. [Managed care, control of costs and the patient's health].
Simonet D
Rev Med Suisse Romande; 2001 Apr; 121(4):269-75. PubMed ID: 11400398
[TBL] [Abstract][Full Text] [Related]
13. Accountable care organizations and ESRD: the time has come.
Nissenson AR; Maddux FW; Velez RL; Mayne TJ; Parks J
Am J Kidney Dis; 2012 May; 59(5):724-33. PubMed ID: 22459132
[TBL] [Abstract][Full Text] [Related]
14. Health care reform, managed care not necessarily threats to ESRD program.
Zawiski MA
Nephrol News Issues; 1994 Jul; 8(7):10-1. PubMed ID: 8047171
[No Abstract] [Full Text] [Related]
15. Cost functions for dialysis facilities and the quality of dialysis.
Escarce JJ; Feldman HI
Health Serv Res; 1999 Feb; 33(6):1563-6. PubMed ID: 10029497
[No Abstract] [Full Text] [Related]
16. Congestive heart failure disease management in Medicare-managed care.
Mehrotra A; McNeil BJ; Landon BE
Am Heart J; 2007 Dec; 154(6):1153-9. PubMed ID: 18035089
[TBL] [Abstract][Full Text] [Related]
17. Can a global payment system work for the ESRD program?
Burton B; Day LM; Pierpoint KL; Vlchek DL
Nephrol News Issues; 1993 Oct; 7(10):18, 20, 22-3. PubMed ID: 8232628
[No Abstract] [Full Text] [Related]
18. Overview of the Medicare and Medicaid programs.
Hoffman ED; Klees BS; Curtis CA
Health Care Financ Rev Stat Suppl; 2002; ():1-378. PubMed ID: 15630768
[No Abstract] [Full Text] [Related]
19. The Canadian health care system as a managed care model for the United States.
Chernomas R; Sepehri A
Health Care Manag; 1995 Oct; 2(1):183-90. PubMed ID: 10165632
[TBL] [Abstract][Full Text] [Related]
20. The Wellpoint/Anthem approach to chronic kidney disease.
Howard RL
Nephrol News Issues; 2005 Nov; 19(12):49-51, 88. PubMed ID: 16315545
[No Abstract] [Full Text] [Related]
[Next] [New Search]
